Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	52.13	-92.92	-194.11
Graham Fair Price	-7.74	73.52	79.69
PEG	-2258.37	-0.63	-0.03
Price/Book	14.23	1.53	1.34
Price/Cash Flow	-76.40	8.00	33.88
Prices/Earnings	29.30	9.17	7.09
Price/Sales	-26.09	1.78	2.40
Price/FCF	-76.40	8.00	33.88
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.28	1.00	1.00
Operating Margin	903.65	0.08	< 0.005
ROA	-14.15	< 0.005	< 0.005
ROE	0.05	0.04	-11.65
ROIC	< 0.005	0.03	1260.52
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.32	0.03	1013.74
Dividends QOQ	< 0.005	0.07	31264.09
EBIT QOQ	0.88	16.17	1741.60
EPS QOQ	2.64	-0.14	-94.52
FCF QOQ	-0.61	3.73	510.42
Revenue QOQ	0.86	0.51	-40.67
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-62682.99	-100.00
Days Sales Outstanding (DSO)	163.47	110.59	-32.35
Inventory Turnover	0.00	< 0.005	-100.00
Debt/Capitalization	0.43	0.50	17.57
Quick Ratio	22.23	4.84	-78.21
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	77.21	75.79	-1.84
Cash	945.73	110.13	-88.36
Capex	0.00	0.00	0.00
Free Cash Flow	3.06	14.54	375.06
Revenue	43.17	65.48	51.70
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	22.23	3.10	-86.03
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-7.28	-16.32	-124.27
Naive Interpretation	Member

06 - Financial Health · Bad

Rating